You are here

Defibrotide

Rare liver disorder drug from Jazz wins U.S. approval

Yahoo/Reuters

Wed, 03/30/16 - 09:19 pm

Jazz Pharmaceuticals

hepatic veno-occlusive disease

4 Pharmaceutical Stocks With Big Catalysts Pending in 2016

24/7 Wall St

Fri, 01/8/16 - 09:43 am

Jazz Pharmaceuticals

Clovis Oncology

Gilead Sciences

Jazz eyes a quick FDA nod for its $1B rare disease drug

Fierce Biotech

Wed, 09/30/15 - 04:49 pm

Jazz Pharmaceuticals

hepatic veno-occlusive disease

Jazz heads to the FDA with its $1B rare disease drug

Fierce Biotech

Mon, 12/15/14 - 08:28 am

Jazz Pharmaceuticals

Jazz Pharma Buys Out Rights To Newly Acquired Drug

Investors.com

Wed, 07/2/14 - 04:38 pm

Jazz Pharmaceuticals

hepatic veno-occlusive disease

Gentium announces completion of defibrotide Phase 1 study in Japan

The Fly on the Wall

Tue, 11/12/13 - 09:48 am

Gentium: Several Underappreciated Investment Positives

Seeking Alpha

Mon, 09/9/13 - 09:51 am

Gentium tumbles 29% on drug setback, downgrade

Marketwatch

Thu, 08/18/11 - 05:44 pm

Gentium Announces NDA Submission for Defibrotide

Yahoo

Wed, 07/6/11 - 08:15 am

veno-occlusive disease